Impaired efferocytosis in human chronic granulomatous disease is reversed by pioglitazone treatment

Impaired efferocytosis in human chronic granulomatous disease is reversed by pioglitazone treatment

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Allergy and Clinical Immunology - Volume 136, Issue 5, November 2015, Pages 1399-1401.e3

Ruby F. PhD, Emilia Liana MD, Christa S. MD, Beatriz E. MD, S. Courtney PhD, Peter M. DVD, PhD, Steven M. MD, Donna L. MD,